• Subscribe

Feature - Dealing with dengue

Feature - Dealing with dengue


Close-up of the Aedis aegypti mosquito that carries dengue. Image courtesy Centers for Disease Control and Prevention (CDC)

First, you get a bad headache. Then your joints feel like they are being crushed. This is followed by fever and a bright red rash on your legs and chest. You may also start vomiting or have diarrhea. This is dengue fever, and it affects two-fifths of the planet's population. Thanks to the EUAsiaGrid project, grid technology is doing its part to help reduce the burden of this devastating disease.

For most, dengue fever passes after a very unpleasant week, but for some it leads to dengue haemorrhagic fever, which is often fatal. Like malaria, dengue is borne by mosquitoes. Unlike malaria, though, it affects people in cities as much as in the countryside. As a result, it has a particularly high incidence in heavily populated parts of South-East Asia, where it is a significant source of infant mortality in several countries.

As yet, there are no drugs that specifically tackle the dengue virus. So the goal of an initiative called Dengue Fever Drug Discovery, launched last July, was to start a systematic search for such drugs, by harnessing grid computing to model how huge databases of chemical compounds would interact with a key replication factor of the dengue virus, potentially knocking it out of action.

This is not the first time that grid technology has been used to amplify the computing power that can be harnessed for such ambitious challenges: malaria and avian flu have been targets of previous massive search efforts, dubbed by experts "in-silico high-throughput screening."

Leading the effort for dengue at Academia Sinica in Taipei is researcher Ying-Ta Wu, of the Genomics Research Center. He and his colleagues prepared some 300,000 virtual compounds to be tested in a couple of months, using the equivalent of over 12 years of the processing power of a single PC.

Map showing prevalence of dengue around the world, and the mosquito associated with it. Image courtesy CDC

Benefits of research

The goal of this exercise, though, was not just to get the processing done quickly. It was also about encouraging partners in Asia to collaborate on sharing the necessary hardware.

These included Universiti Putra Malaysia and the MIMOS Berhad Institute in Malaysia, the Institute of Applied Mathematics and Informatics in Vietnam and the Hydro and Agro Informatics Institute of Thailand, as well as CESNET, an academic network operator in the Czech Republic.

The successful collaboration is a testament to efforts by the EUAsiaGrid project, led by the Academia Sinica Grid Computing Center in Asia and INFN in Italy, to attract new partners in South-East Asia to grid computing, and to train them in how to deploy and run the necessary middleware in their own institutes. In this case, the GAP-based Virtual Screen Service (GVSS) was used - an application package that combines the EGEE gLite middleware with a drug docking simulation package called Autodock.

"We will have to wait a while to judge the final result of this effort," says Ying-Ta Wu. Indeed, after sorting out the most promising drug candidates, researchers must now begin the arduous task of testing these drugs on real viruses. And even if successful candidates are found, there is still a long way to a product that can be safely administered to people suffering from dengue.

But at least, thanks to grid computing, an important first step has been taken down that road.

-François Grey, for EUAsia Grid

Join the conversation

Do you have story ideas or something to contribute? Let us know!

Copyright © 2022 Science Node ™  |  Privacy Notice  |  Sitemap

Disclaimer: While Science Node ™ does its best to provide complete and up-to-date information, it does not warrant that the information is error-free and disclaims all liability with respect to results from the use of the information.

Republish

We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit ScienceNode.org — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on ScienceNode.org” containing a link back to the original article.
  4. The easiest way to get the article on your site is to embed the code below.